Dual Antidiabetic Combination
Contains Teneligliptin, a DPP-4 inhibitor, and Metformin SR, a biguanide antidiabetic agent, providing complementary mechanisms to improve glycemic control in patients with type 2 diabetes.
Loading...
Loading...
Teneligliptin 20mg With Metformin Hydrochloride 500mg (Sustained Release ) Tablets
A dual-action oral antidiabetic formulation designed for effective management of type 2 diabetes mellitus. TENLISTEL-M combines teneligliptin and sustained-release metformin to improve insulin secretion, reduce hepatic glucose production, and maintain stable blood glucose levels throughout the day.
A dual-action oral antidiabetic formulation designed for effective management of type 2 diabetes mellitus. TENLISTEL-M combines teneligliptin and sustained-release metformin to improve insulin secretion, reduce hepatic glucose production, and maintain stable blood glucose levels throughout the day.
Contains Teneligliptin, a DPP-4 inhibitor, and Metformin SR, a biguanide antidiabetic agent, providing complementary mechanisms to improve glycemic control in patients with type 2 diabetes.
Teneligliptin inhibits the DPP-4 enzyme, increasing incretin hormone levels that stimulate insulin secretion and reduce glucagon release after meals, thereby lowering blood glucose levels.
Metformin works by decreasing glucose production in the liver and improving peripheral insulin sensitivity, allowing body cells to utilize glucose more effectively.
Sust...
Product descriptions, dosage forms, and compositions listed on the website are for reference by licensed practitioners and distributors only.
